NCT02251860View on ClinicalTrials.gov

Study of Tocilizumab (RoActemre) Administered Subcutaneously in Participants With Rheumatoid Arthritis in Everyday Clinical Practice

CompletedOBSERVATIONAL
Enrollment

1,454

Participants

Timeline

Start Date

May 20, 2014

Primary Completion Date

July 23, 2020

Study Completion Date

July 23, 2020

Conditions
Rheumatoid Arthritis
Trial Locations (1)

60528

CIRI - Centrum für Innovative Diagnostik und Therapie Rheumatologie/ Immunologie (GmbH), Frankfurt

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

collaborator

Chugai Pharma Europe Ltd.

INDUSTRY

NCT02251860 - Study of Tocilizumab (RoActemre) Administered Subcutaneously in Participants With Rheumatoid Arthritis in Everyday Clinical Practice | Biotech Hunter | Biotech Hunter